Press releaseGlobe Newswire
Vericel
VCEL · NASDAQ
$40.58+$0.21 (+0.52%)TodayMarket closed ·
Prev close $40.37
Latest news
- Press releaseGlobe Newswire
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
- Press releaseGlobe Newswire
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
- News
Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate
- Press releaseGlobe Newswire
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
- Press releaseGlobe Newswire
Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild Itself
- Press releaseGlobe Newswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
- Press releaseGlobe Newswire
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
- Press releaseGlobe Newswire
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
- Press releasePRNewswire
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
- Press releaseGlobe Newswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
- News
Earnings Breakdown: Vericel Q4
- News
Vericel Q4 EPS $0.45 Beats $0.39 Estimate, Sales $92.918M Beat $91.122M Estimate
- Press releaseGlobe Newswire
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
- News
Earnings Scheduled For February 26, 2026
- NewsAkanksha Bakshi
Why Is Vericel Stock Gaining Tuesday?
- News
Earnings Scheduled For November 6, 2025
- News
Earnings Scheduled For May 8, 2025
- NewsAvi Kapoor
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- News
Market-Moving News for January 15th
- NewsAvi Kapoor
Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.